| Name | Trk-IN-3 |
|---|---|
| Synonyms |
PF-06733804 >= (HPLC)
3-Pyridinecboxamide, 6-amino-5-[[(3S)-4,4-difluoro-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]-3-pyrrolidinyl]oxy]-N-methyl PF-06733804 PF06733804,PF |
| Description | Trk-IN-3 is a potent pan-Trk inhibitor in cell-based assays with IC50s of 8.4 nM, 6.2 nM and 2.2 nM for TrkA, TrkB and TrkC, respectively[1]. Anti-hyperalgesic effect[1]. |
|---|---|
| Related Catalog | |
| Target |
TrkA:8.4 nM (IC50, in cell-based assays) TrkB:6.2 nM (IC50, in cell-based assays) TrkC:2.2 nM (IC50, in cell-based assays) |
| In Vitro | Trk-IN-3 (Compound 19) also inhibits hERG in the FP and PX assay with IC50s of 79 μM and 88 μM, respectively[1]. |
| References |
| Molecular Formula | C20H19F5N4O4 |
|---|---|
| Molecular Weight | 474.38 |
| Hazard Codes | Xi |
|---|